Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer’s disease, ...
read more
Thursday, February 01, 2024
Biovian and 3P Biopharmaceuticals (“3P”), two biologics Contract Development and Manufacturing Organizations (CDMOs), announced their combination to establish a new pan-European leader in their field.
read more
27th April 2012 - Recipharm Ltd in Ashton under Lyne, UK is pleased to launch a dedicated recovery service for reworking pharmaceutical products under cGMP conditions at its UK site.
read more
Wednesday, December 14, 2016
ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health. Under this agreement, ConverGene has the rights to commercialize jointly ...
read more
Wednesday, January 27, 2021
MedPharm has launched its Scientific Advisory Committee, headed by company founder and Board member, Professor Marc Brown.
read more
Tuesday, September 21, 2021
Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, and Hainan Poly Pharm Co, a generics manufacturer dedicated to providing therapeutic-value products and services to patients and customers ...
read more
Tuesday, October 26, 2021
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services...
read more
Friday, September 11, 2020
Catalent is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Maryland.
read more
Wednesday, August 26, 2015
Alvogen has entered into a definitive agreement with Pfizer under which it will acquire a portfolio of four pharmaceutical products.
read more
Friday, September 15, 2017
SCA Pharmaceuticals announced the appointment of Milton Boyer as Chief Executive Officer.
read more
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
read more
Swiss medical device manufacturer Ypsomed AG has announced a $248 million investment to establish its first manufacturing facility in the United States, marking a major milestone in the company’s international expansion strategy.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new lab has been in operation since August 1 2021.
read more
Wednesday, April 03, 2013
The new Secura laboratory balance developed by Sartorius for applications in regulated areas such as pharmaceutical labs fulfills particularly high reliability requirements. The balance monitors its ambient conditions automatically, thereby ...
read more
Wednesday, October 11, 2017
Shimadzu Instrumentation Corporation announces a collaboration with VpH, to establish the Medical Botanical Center of Excellence.
read more